Cargando…
An Altered Pattern of Myocardial Histopathological and Molecular Changes Underlies the Different Characteristics of Type-1 and Type-2 Diabetic Cardiac Dysfunction
Increasing evidence suggests that both types of diabetes mellitus (DM) lead to cardiac structural and functional changes. In this study we investigated and compared functional characteristics and underlying subcellular pathological features in rat models of type-1 and type-2 diabetic cardiomyopathy....
Autores principales: | Radovits, Tamás, Korkmaz, Sevil, Mátyás, Csaba, Oláh, Attila, Németh, Balázs Tamás, Páli, Szabolcs, Hirschberg, Kristóf, Zubarevich, Alina, Gwanmesia, Patricia Neh, Li, Shiliang, Loganathan, Sivakkanan, Barnucz, Enikő, Merkely, Béla, Szabó, Gábor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4300149/ https://www.ncbi.nlm.nih.gov/pubmed/25629059 http://dx.doi.org/10.1155/2015/728741 |
Ejemplares similares
-
Pharmacological activation of soluble guanylate cyclase activator protects the heart against isoproterenol-induced myocardial ischemia in rats
por: Korkmaz, Sevil, et al.
Publicado: (2009) -
Acute Ethanol Exposure Increases the Susceptibility of the Donor Hearts to Ischemia/Reperfusion Injury after Transplantation in Rats
por: Li, Shiliang, et al.
Publicado: (2012) -
Phosphodiesterase-5 inhibition delays cardiac dilation and improves myocardial function in a rat model of heart failure due to chronic volume overload
por: Loganathan, Sivakkanan, et al.
Publicado: (2009) -
The soluble guanylate cyclase activator cinaciguat prevents cardiac dysfunction in a rat model of type-1 diabetes mellitus
por: Mátyás, Csaba, et al.
Publicado: (2015) -
Pharmacological preconditioning with the guanylate cyclase activator cinaciguat (BAY 58-2667) protects against reperfusion injury after cardiopulmonary bypass
por: Radovits, Tamás, et al.
Publicado: (2009)